Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0150
+0.0010 (7.14%)
Jun 19, 2026, 4:10 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 57.46 million as of June 18, 2026. Its market cap has increased by 352.63% in one year.
Market Cap
57.46M
Enterprise Value
52.81M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 57.46M, an increase of 45.99%. That is a compound annual growth rate of 1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 57.46M | 73.79% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 70.88M |
| Immutep | 70.74M |
| Prescient Therapeutics | 68.35M |
| Cynata Therapeutics | 63.30M |
| Botanix Pharmaceuticals | 62.89M |
| Amplia Therapeutics | 56.46M |
| Entropy Neurodynamics | 52.22M |
| Neurizon Therapeutics | 50.75M |